CONSOL Remains Top Pick in Coal Space and 4 Stock Analyses to Know Now

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Current Price: $177.93

RBC Capital thinks that Regeneron is at an attractive entry point due to its belief that the market is undervaluing the near-term market opportunity of Regeneron’s Eylea treatment along with its broader pipeline. The firm recommends purchasing the stock on pullbacks and it keeps its Outperform rating on the stock.

Markets are off to the races and this stock is on fire. Click here to discover it now!


More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business